Cargando…
Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model
Patients with asthma with obesity experience severe symptoms, are unresponsive to conventional asthma treatment, and lack proper pharmacotherapy. Empagliflozin and dulaglutide, developed for diabetes, reduce weight, decrease insulin resistance, and exert additive effects. We evaluated the efficacy o...
Autores principales: | Park, Hye Jung, Han, Heejae, Oh, Eun-Yi, Kim, Sung Ryeol, Park, Kyung Hee, Lee, Jae-Hyun, Park, Jung-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821734/ https://www.ncbi.nlm.nih.gov/pubmed/31666643 http://dx.doi.org/10.1038/s41598-019-51648-1 |
Ejemplares similares
-
Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-β1 pathway
por: Park, Yoon Hee, et al.
Publicado: (2019) -
Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles
por: Park, Hee Sun, et al.
Publicado: (2010) -
Obesity Increases Airway Hyperresponsiveness via the TNF-α Pathway and Treating Obesity Induces Recovery
por: Kim, Joo Young, et al.
Publicado: (2015) -
Effects of Particulate Matter 10 Inhalation on Lung Tissue RNA expression in a Murine Model
por: Han, Heejae, et al.
Publicado: (2021) -
Ultra-high-resolution computed tomography shows changes in the lungs related with airway hyperresponsiveness in a murine asthma model
por: Jung, Jae-Woo, et al.
Publicado: (2021)